Senseonics Holdings, Inc. (SENS) is a Technology stock trading at $6.72 (as of 2026-06-18), with a market capitalization of $283.84M and a trailing P/E of -2.9. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Senseonics Holdings, Inc. develops and commercializes continuous glucose monitoring systems for people with diabetes, including the Eversense and Eversense XL implantable platforms that measure glucose via an under-the-skin sensor and transmit data to an app through a removable, rechargeable smart transmitter. Its systems are sold in the United States, Europe, the Middle East, and Africa, serving patients through healthcare providers via distributor and fulfillment partner channels.